Global Allergy Diagnostics Market (2021 to 2026) - Featuring Thermo Fisher Scientific, Danaher and Neogen Among Others

News provided by

Nov 18, 2021, 10:15 ET

DUBLIN, Nov. 18, 2021 /PRNewswire/ -- The "Global Allergy Diagnostics Market by Product & Service (Consumables, Instruments (Immunoassay Analyzer, ELISA Analyzer, Luminometer), Service), Allergen (Food, Inhaled, Drug), Test Type (In Vivo, In Vitro), End-user (Diagnostic Laboratories), and Region - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

The global allergy diagnostics market is projected to USD 8.2 billion by 2026 from USD 4.8 billion in 2021, at a CAGR of 11.1% from 2021 to 2026.

The growth of this market is driven owing to the high incidence of allergic diseases and associated heavy economical burden, rising environmental pollution levels, increasing funds by organizations in allergy diagnostics, and the increasing access to healthcare insurance. Also, use of mHealth in allergy diagnosis is anticipated to offer an opportunity for the growth of the market during the forecast period.

Consumables are expected to hold the largest share of the allergy diagnostics market, by product & service in 2021

Based on product & service, the allergy diagnostics market is segmented into consumables, instruments, and services. In 2020, the consumables segment accounted for the largest share of the allergy diagnostics market. The large share of the consumables segment can be attributed to the increasing cases of allergies and the need for rapid tests to diagnose allergic conditions. The consumables segment is also expected to witness significant growth during the forecast period.

In vivo tests are expected to hold the largest share of the allergy diagnostics market, by test type in 2021

Based on test type, the allergy diagnostics market is segmented into in vivo tests and in vitro tests. In 2020, the in vivo tests segment accounted for the largest share of the allergy diagnostics market. The growth of this segment is mainly driven by the increasing adoption of various in vivo tests, such as skin prick tests. These tests are dependable, safe, convenient, and cost-effective, as compared to in vitro tests.

Inhaled allergens are expected to hold the largest share of the allergy diagnostics market, by allergen in 2021

Based on allergens, the allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2020, the inhaled allergens segment accounted for the largest share of the allergy diagnostics market due to the increasing environmental pollution and rising pollen coupled with other factors such as fungus, mold, and dust.

Diagnostic laboratories are expected to hold the largest share of the allergy diagnostics market, by end user in 2021

Based on end user, the allergy diagnostics market is segmented into diagnostic laboratories, hospital-based laboratories, academic research institutes, and other end users. In 2020, the diagnostic laboratories segment accounted for the largest share of the market. The large share of the segment can be primarily attributed to the preference for proper diagnosis from a specialist, rising awareness regarding the management of allergic diseases, and the availability of funds for the operation of independent diagnostic laboratories.

North America commanded the largest share of the allergy diagnostics market in 2021

Based on region, the allergy diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America commanded the largest share of the allergy diagnostics market. The large share of North America can be attributed to the rising incidence of allergies, favorable reimbursement scenarios for allergy diagnosis, and the availability of supportive initiatives by associations.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Allergy Diagnostics Market Overview
4.2 Asia-Pacific: Allergy Diagnostics Market Share, by Allergen (2020)
4.3 Geographical Snapshot of the Allergy Diagnostics Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 The High Incidence and Heavy Economic Burden of Allergic Diseases
5.2.1.2 Rising Environmental Pollution Levels
5.2.1.3 Increasing Funding Initiatives in Allergy Diagnostics
5.2.1.4 Growing Access to Health Insurance
5.2.2 Restraints
5.2.2.1 Premium Costs Associated with Allergy Diagnostic Instruments
5.2.2.2 Limited Awareness and Poor Implementation of Allergy Testing Methods
5.2.3 Opportunities
5.2.3.1 Use of mHealth in Allergy Diagnosis
5.2.4 Challenges
5.2.4.1 Shortage of Allergists
5.2.5 Trends
5.2.5.1 Reagent Rental Agreements
5.3 Supply Chain Analysis
5.4 Value Chain Analysis
5.5 Ecosystem Analysis of the Allergy Diagnostics Market
5.5.1 Role in the Ecosystem
5.6 Pricing Analysis
5.7 Regulatory Overview
5.8 Trade Analysis
5.8.1 Import Data for Hs Code 902750, by Country, 2016-2020 (USD Thousand)
5.8.2 Export Data for Hs Code 902750, by Country, 2017-2019 (USD Thousand)
5.8.3 Export Data for Hs Code 902750, by Country, 2016-2020
5.8.4 Import Data for Hs Code 902750, by Country, 2016-2020
5.9 Patent Analysis
5.9.1 Patent Analysis: Luminometers
5.10 Technology Analysis
5.11 Porter's Five Forces Analysis
5.12 COVID-19 Impact Analysis for the Allergy Diagnostics Market
5.13 Ranges/Scenarios
5.14 Trends/Disruptions Impacting Customer Businesses

6 Allergy Diagnostics Market, by Product & Service
6.1 Introduction
6.2 Consumables
6.2.1 Consumables are the Most Widely Used Products for Allergy Testing
6.3 Instruments
6.3.1 Immunoassay Analyzers
6.3.1.1 Immunoassay Analyzers are Highly Preferred for Allergy Diagnostics
6.3.2 Elisa Analyzers
6.3.2.1 The Precision Offered by Elisa Tests to Propel the Growth of the Segment
6.3.3 Luminometers
6.3.3.1 Luminometers are Convenient to Use, Thus Leading to Their Increased Adoption
6.3.4 Other Instruments
6.4 Services
6.4.1 Rising Cases of Allergies to Drive the Growth of the Services Segment

7 Allergy Diagnostics Market, by Test Type
7.1 Introduction
7.2 In Vivo Tests
7.2.1 Skin Prick Tests
7.2.1.1 Skin Prick Tests are the Most Widely Preferred in Vivo Allergy Tests
7.2.2 Patch Tests
7.2.2.1 Patch Tests Help in the Diagnosis of Contact Dermatitis, Unlike the Skin Prick Test
7.2.3 Other in Vivo Tests
7.3 In Vitro Tests
7.3.1 In Vitro Allergy Tests are Set to Witness Significant Growth During the Forecast Period

8 Allergy Diagnostics Market, by Allergen
8.1 Introduction
8.2 Inhaled Allergens
8.2.1 Inhaled Allergens Dominated the Market in 2020
8.3 Food Allergens
8.3.1 Food Allergy is Found to be More Prevalent Among Children
8.4 Drug Allergens
8.4.1 The Drug Allergy Segment is Expected to Witness Considerable Growth During the Forecast Period
8.5 Other Allergens

9 Allergy Diagnostics Market, by End-user
9.1 Introduction
9.2 Diagnostic Laboratories
9.2.1 Diagnostic Laboratories Accounted for the Largest Share of the End-User Market in 2020
9.3 Hospital-based Laboratories
9.3.1 Hospital-based Laboratories are More Accessible to Patients and Offer Rapid Results
9.4 Academic Research Institutes
9.4.1 Grants Offered by Organizations to Support the Growth of this Segment
9.5 Other End-users

10 Allergy Diagnostics Market, by Region

11 Competitive Landscape
11.1 Overview
11.2 Key Player Strategies/Right to Win
11.2.1 Overview of Strategies Adopted by Key Players in the Market
11.3 Revenue Analysis
11.4 Market Share Analysis
11.5 Company Evaluation Quadrant (Major Players)
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
11.6 Competitive Leadership Mapping (Start-Ups and SMEs)
11.6.1 Progressive Companies
11.6.2 Starting Blocks
11.6.3 Responsive Companies
11.6.4 Dynamic Companies
11.7 Company Footprint
11.8 Competitive Scenario and Trends
11.8.1 Deals
11.8.2 Product Launches
11.8.3 Expansions
11.8.4 Other Developments

12 Company Profiles
12.1 Key Players
12.1.1 Thermo Fisher Scientific Inc.
12.1.2 Danaher
12.1.3 Minaris Medical America, Inc.
12.1.4 Siemens Healthineers AG
12.1.5 Eurofins Scientific
12.1.6 Euroimmun Medizinische Labordiagnostika AG
12.1.7 bioMerieux SA
12.1.8 Stallergenes Greer Ltd
12.1.9 Romer Labs Division Holding GmbH
12.1.10 Neogen Corporation
12.1.11 Hollisterstier Allergy
12.1.12 Omega Diagnostics Group plc
12.2 Other Players
12.2.1 Hob Biotech Group Corp. Ltd.
12.2.2 Hycor Biomedical
12.2.3 Lincoln Diagnostics, Inc.
12.2.4 R-Biopharm AG
12.2.5 Astra Biotech GmbH
12.2.6 Erba Group
12.2.7 Aesku.Group GmbH
12.2.8 Acon Laboratories, Inc.